Fertility Preservation Safe for Young Women with Breast Cancer

In the United States, large barriers remain for women with cancer who want to preserve their fertility, explained Dr. Levine. For instance, while fertility preservation is available to all women in Sweden under their national health system, many insurance plans in the United States don’t cover it for young cancer patients.

Study of “exceptional responders” yields clues to cancer and potential treatments

USA, 19th November 2020. In a comprehensive analysis of patients with cancer who had exceptional responses to therapy, researchers have identified molecular changes in the patients’ tumours that may explain some of the exceptional responses. The results demonstrate that genomic characterizations of cancer can uncover genetic alterations that may contribute to unexpected and long-lasting responses…… Continue reading Study of “exceptional responders” yields clues to cancer and potential treatments

Study confirms effective, less toxic alternative to standard treatment for adults with Burkitt lymphoma

Washington DC. 26th May 2020. In a new study, an alternative treatment regimen that is less toxic than standard dose-intensive chemotherapy was found to be highly effective for adults with Burkitt lymphoma across all age groups and independent of HIV status. In addition to being better tolerated, the regimen, called dose-adjusted (DA) EPOCH-R, is already…… Continue reading Study confirms effective, less toxic alternative to standard treatment for adults with Burkitt lymphoma

Should we delay Blood cancer treatment during Corona Virus Pandemic?

Blood cancer called acute Leukemia is ‘The most dangerous and life-threatening Cancer’ where early initiation of treatment makes a huge difference in patient outcome. Clinical Presentation of Blood cancer is variable ranging from Incidental detection on blood tests to breathing difficulty and fever. These symptoms trigger Corona testing and Isolation. With the fear of COVID19…… Continue reading Should we delay Blood cancer treatment during Corona Virus Pandemic?

In NIH trial, selumetinib shrinks tumors, provides clinical benefit for children with NF1

New York. 19th March 2020 : Findings from a phase 2 clinical trial show that the drug selumetinib improves outcomes for children with the genetic disorder neurofibromatosis type 1 (NF1). In the trial, selumetinib shrank the inoperable tumors that develop with NF1 called plexiform neurofibromas, and children experienced reduced pain, improved function, and better overall…… Continue reading In NIH trial, selumetinib shrinks tumors, provides clinical benefit for children with NF1

Study provides genetic insights into osteosarcoma in children

New York 19th March 2020 : A study by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, offers new insight into genetic alterations associated with osteosarcoma, the most common cancerous bone tumour of children and adolescents. The researchers found that more people with osteosarcoma carry harmful, or likely harmful,…… Continue reading Study provides genetic insights into osteosarcoma in children

In India, around 5.8 lakh new cases of cancers were diagnosed in women in 2018

In 2020, American Oncology Institute will create 2020 Nyla Volunteers across 13 states in India American Oncology Institute announces the launch of its exclusive Campaign for ‘Cancers in Women’- NYLA, a movement for early detection and prevention of Cancers in Women  Hyderabad, February 09, 2020: American Oncology Institute (AOI), South Asia’s leading chain of cancer…… Continue reading In India, around 5.8 lakh new cases of cancers were diagnosed in women in 2018

Global cancer burden expected to rise by 60% by 2040!

World Cancer Day – February 4, 2020  February 4, 2020, will mark the 20th anniversary of World Cancer Day, an annual event meant to raise cancer awareness and encourage governments, oncology societies, nongovernmental organizations, businesses, and individuals to take action against the global impact of the disease. This has been formed in recognition to make…… Continue reading Global cancer burden expected to rise by 60% by 2040!

Artificial intelligenc can jump-start radiation therapy for cancer patients

instantly generates dosage plan, avoids potentially crucial delay DALLAS – Jan. 27, 2020 – Artificial intelligence can help cancer patients start their radiation therapy sooner – and thereby decrease the odds of the cancer spreading – by instantly translating complex clinical data into an optimal plan of attack. Patients typically must wait several days to…… Continue reading Artificial intelligenc can jump-start radiation therapy for cancer patients

UT Southwestern cancer experts catalog, map kidney cancer tumors and progression

DALLAS – Jan. 13, 2020 – Researchers at the Kidney Cancer Program at UT Southwestern Medical Center’s Harold C. Simmons Comprehensive Cancer Center have developed what could be the most complete catalog of clear cell renal cell carcinoma, the most common type of kidney cancer. Known as ccRCC, this cancer is marked by a high…… Continue reading UT Southwestern cancer experts catalog, map kidney cancer tumors and progression

Apollo Doctors perform Living Donor Liver Transplant and CABG, in one sitting spanning over a gruelling 14 hours!

The 67 year old patient Mr Siva Prasad Rao (2nd from left), briefing media about the rare and complex Living Donor Liver Transplant and CABG, he underwent at Apollo Hospitals, in one sitting spanning over 14 hours, for the Liver Cirrhosis, Liver cancer and coronary artery disease he was suffering from, at a press conference, today at Apollo Hospitals, Jubilee Hills, as (L-R) Dr Hari Prasad, President, Hospitals Division, Apollo Hospitals Group; Mrs Rohini, patient's daughter & liver donor; Dr Manoj Agarwala, Sr Consultant Cardiologist; Dr Naveen Polavarapu, Consultant, Gastroenterologist; Dr Manish C. Varma, HOD, Liver Transplant, Apollo Hospitals, look on.

The treatment involved expertise of multiple specialities including Liver transplant, Oncology & Cardiac teams

Criteria for clinical trials might be too strict, needlessly excluding patients

Clinical trial eligibility criteria are designed to limit risks to study participants. But, according to Dr. Gerber, these criteria may be excessive in places.

Fewer Women with Ovarian, Breast Cancer Undergo Genetic Testing than Expected

Tests for inherited genetic mutations can provide women diagnosed with ovarian or breast cancer with important information that can have implications for family members and potentially guide treatment decisions and longer-term screening for second cancers.

Analysis Shows Women with High Breast Cancer Recurrence Scores Benefit from Chemo

For women with the most common type of early-stage breast cancer and high scores on the Oncotype DX test, receiving chemotherapy with hormone therapy after surgery can lead to excellent long-term outcomes.

For Children with Neuroblastoma, Trial Results Highlight Continued Evolution of Treatment

For many children with advanced forms of neuroblastoma, receiving two separate stem cell transplants as part of their treatment is more beneficial than receiving one.

Selpercatinib Shows Promise against Lung Cancers with Alterations in RET Gene

Selpercatinib (LOXO-292) is a targeted therapy that works by inhibiting the activity of abnormal RET proteins. The drug is an oral therapy that patients take as a pill.

Exit mobile version